MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Evolution of biochemical and clinical signature of GBA-related Parkinson’s Disease: a 2-year longitudinal study

    M. Avenali, S. Cerri, G. Ongari, C. Pacchetti, C. Tassorelli, EM. Valente, F. Blandini (Pavia, Italy)

    Objective: To evaluate peripheral biochemical markers as well as clinical features of GBA-related Parkinson’s Disease (GBA-PD) subjects over a 2-year follow-up in comparison with NM-PD…
  • 2022 International Congress

    Systematic Literature Review of Key Outcomes Used to Assess Adjunctive Treatments for Parkinson’s Disease

    A. Thach, M. Zichlin, M. Peddle, M. Du, A. Lerner, N. Kirson, A. Bowling, D. Mehta, R. Williams (Marlborough, USA)

    Objective: Understand key efficacy outcomes used to assess adjunctive treatments to carbidopa/levodopa (CD/LD) for Parkinson’s disease (PD). Background: CD/LD is widely considered the most effective…
  • 2022 International Congress

    Detection of Parkinson’s Disease by Analysis of Smooth Pursuit Eye Movements and Machine Learning

    M. Bejani, E. Luque-Buzo, J. Gomez-García, A. Burlaka-Petrash, F. Grandas, J. Godino-Llorente (Madrid, Spain)

    Objective: The present study investigates an automatic method to parameterize smooth pursuit eye movements (SPEM) and to differentiate Parkinson's disease (PD) from controls using machine…
  • 2022 International Congress

    Transcutaneous auricular vagal nerve stimulation has frequency depended propensity to improve gait in Parkinson’s disease – a pilot study

    V. van Midden, Z. Pirtošek, G. Brecl Jakob, M. Kojović (Ljubljana, Slovenia)

    Objective: We used wearable inertion motion sensors (WMS) to compare the acute effects of transcutaneous auricular vagal stimulation (taVNS) at 100Hz (taVNS100), 25Hz (taVNS25), and…
  • 2022 International Congress

    The Spectrum of Movement Disorders Associated With NUS1 Pathogenic Variants

    NE. Mencacci, N. Prakash, E. Gerard, L. Kinsley, BK. Bölsterli, R. Steinfeld, C. Ellis, T. Tropea, T. Bardakjian, A. Lavillaureix, M. Ugolin, C. Thauvin-Robinet, M. Brugger, KM. Riedhammer, T. Opladen, T. Wirth, C. Tranchant, M. Anheim, J. Chelly, BA. Mendelsohn, S. Nandipati, A. Stembridge, HS. Dafsari, H. Zempel, P. Herkenrath, S. Mercimek-Andrews, T. Laut, J. Necpal, R. Jech, M. Zech, G. Trieschmann, S. Berweck, O. Vanakker, D. Gill, F. Gardiner, S. Mohammad, H. Mefford, I. Scheffer, G. Carvill, D. Krainc (Chicago, USA)

    Objective: To explore the phenotype of NUS1-related disorders and determine the spectrum of movement disorders in patients with NUS1 pathogenic variants. Background: A growing body…
  • 2022 International Congress

    Role of the cerebellocortical pathway in the pathophysiology of adult with Tourette’s syndrome

    P. álvarez Toledo, JF. Martín-Rodríguez, P. Franco Rosado, E. Iglesias Camacho, B. Villarreal, S. Jesús, F. Carrillo, L. Garrote Espina, L. Muñoz-Delgado, C. Ganos, P. Mir (Sevilla, Spain)

    Objective: To assess state-dependent cerebellar-cortical connectivity, through transcranial magnetic stimulation (TMS), in adult patients with Tourette Syndrome (TS) during a voluntary tic inhibition task. A…
  • 2022 International Congress

    Performance of Parkinson´s disease cognitive scale rating scale (PD-CRS) after 2 years Subthalamic nucleus deep brain stimulation. Comparison with Mattis Dementia Rating Scale (MDRS) and Mini-Mental State Examination (MMSE)

    C. García-Sánchez, C. Pons, N. Grunden, B. Pascual-Sedano, A. Gironell, R. Rodriguez, J. Kulisevsky (Barcelona, Spain)

    Objective: To study the performance of PD-CRS before and 2 years after STN-DBS and compare their results with other recognized cognitive scales. Background: Parkinson´s disease…
  • 2022 International Congress

    Exploring Driving Behaviour in Patients with Functional Neurological Disorders (FND)

    TJ. Lagrand (Brisbane, Australia)

    Objective: The overarching objective of this study is to explore driving behaviour in individuals with FND phenotypes. Specifically, this research aims to enhance understanding of…
  • 2022 International Congress

    Frequency of non- motor symptoms in dystonia patients

    V. Vuletic (Rijeka, Croatia)

    Objective: Our aim was to see a frequency of non-motor symptoms (NMS) in dystonia patients and influence on quality of life (QoL). Background: Non-motor problems…
  • 2022 International Congress

    DIFFERENCE IN MOTOR AND NONMOTOR SYMPTOMS BETWEEN YOUNG AND LATE ONSET PARKINSON`S DISEASE

    LH. Horvat, Z. Popovic, T. Gilman Kuric, I. Rajkovaca Latic, T. Mirosevic Zubonja, J. Kragujevic, S. Tomic ()

    Objective: To evaluate difference in prevalence of nonmotor symptoms and severity of autonomic and motor symptoms between patients with young (YOPD) and late onset (LOPD)…
  • « Previous Page
  • 1
  • …
  • 632
  • 633
  • 634
  • 635
  • 636
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley